Literature DB >> 20106930

Expression of varicella-zoster virus immediate-early regulatory protein IE63 in neurons of latently infected human sensory ganglia.

Leigh Zerboni1, Raymond A Sobel, Vasavi Ramachandran, Jaya Rajamani, William Ruyechan, Allison Abendroth, Ann Arvin.   

Abstract

Varicella-zoster virus (VZV) causes varicella and establishes latency in sensory nerve ganglia, but the characteristics of VZV latency are not well defined. Immunohistochemical detection of the VZV immediate-early 63 (IE63) protein in ganglion neurons has been described, but there are significant discrepancies in estimates of the frequency of IE63-positive neurons, varying from a rare event to abundant expression. We examined IE63 expression in cadaver ganglia using a high-potency rabbit anti-IE63 antibody and corresponding preimmune serum. Using standard immunohistochemical techniques, we evaluated 10 ganglia that contained VZV DNA from seven individuals. These experiments showed that neuronal pigments were a confounding variable; however, by examining sections coded to prevent investigator bias and applying statistical analysis, we determined that IE63 protein, if present, is in a very small proportion of neurons (<2.8%). To refine estimates of IE63 protein abundance, we modified our protocol by incorporating a biological stain to exclude the pigment signal and evaluated 27 ganglia from 18 individuals. We identified IE63 protein in neurons within only one ganglion, in which VZV glycoprotein E and an immune cell infiltrate were also demonstrated. Antigen preservation was shown by detection of neuronal synaptophysin. These data provide evidence that the expression of IE63 protein, which has been referred to as a latency-associated protein, is rare. Refining estimates of VZV protein expression in neurons is important for developing a hypothesis about the mechanisms by which VZV latency may be maintained.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20106930      PMCID: PMC2838126          DOI: 10.1128/JVI.02416-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Pigments in aging: an overview.

Authors:  Eduardo A Porta
Journal:  Ann N Y Acad Sci       Date:  2002-04       Impact factor: 5.691

2.  Varicella-zoster virus gene expression in latently infected and explanted human ganglia.

Authors:  P G Kennedy; E Grinfeld; J E Bell
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

3.  ELECTRON MICROSCOPY OF THE TRIGEMINAL GANGLION. II. AUTOPSY STUDY OF HUMAN GANGLIA.

Authors:  D L BEAVER; H L MOSES; C E GANOTE
Journal:  Arch Pathol       Date:  1965-06

4.  A Nile blue staining technic for the differentiation of melanin and lipofuscins.

Authors:  R D LILLIE
Journal:  Stain Technol       Date:  1956-07

5.  A comparison of melanin bleaching and azure blue counterstaining in the immunohistochemical diagnosis of malignant melanoma.

Authors:  C J Kligora; K P Fair; M S Clem; J W Patterson
Journal:  Mod Pathol       Date:  1999-12       Impact factor: 7.842

6.  Physical and functional interaction between the varicella zoster virus IE63 and IE62 proteins.

Authors:  Jennifer M Lynch; Terri K Kenyon; Charles Grose; John Hay; William T Ruyechan
Journal:  Virology       Date:  2002-10-10       Impact factor: 3.616

7.  Oxidatively modified GST and MRP1 in Alzheimer's disease brain: implications for accumulation of reactive lipid peroxidation products.

Authors:  Rukhsana Sultana; D Allan Butterfield
Journal:  Neurochem Res       Date:  2004-12       Impact factor: 3.996

8.  Varicella-zoster virus infection of human dorsal root ganglia in vivo.

Authors:  Leigh Zerboni; Chia-Chi Ku; Carol D Jones; James L Zehnder; Ann M Arvin
Journal:  Proc Natl Acad Sci U S A       Date:  2005-04-25       Impact factor: 11.205

9.  Translation of varicella-zoster virus genes during human ganglionic latency.

Authors:  Esther Grinfeld; Peter G E Kennedy
Journal:  Virus Genes       Date:  2004-12       Impact factor: 2.332

10.  Phosphorylation of the nuclear form of varicella-zoster virus immediate-early protein 63 by casein kinase II at serine 186.

Authors:  Niklaus H Mueller; Laurie L Graf; David Orlicky; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2009-09-16       Impact factor: 5.103

View more
  30 in total

1.  Neutralizing anti-gH antibody of Varicella-zoster virus modulates distribution of gH and induces gene regulation, mimicking latency.

Authors:  Kimiyasu Shiraki; Tohru Daikoku; Masaya Takemoto; Yoshihiro Yoshida; Kazuhiro Suzuki; Yasushi Akahori; Toshiomi Okuno; Yoshikazu Kurosawa; Yoshizo Asano
Journal:  J Virol       Date:  2011-06-01       Impact factor: 5.103

2.  Effect of time delay after necropsy on analysis of simian varicella-zoster virus expression in latently infected ganglia of rhesus macaques.

Authors:  Ravi Mahalingam; Vicki Traina-Dorge; Mary Wellish; Eileen Deharo; Anjani Golive; Ilhem Messaoudi; Don Gilden
Journal:  J Virol       Date:  2010-09-22       Impact factor: 5.103

3.  Apparent expression of varicella-zoster virus proteins in latency resulting from reactivity of murine and rabbit antibodies with human blood group a determinants in sensory neurons.

Authors:  Leigh Zerboni; Raymond A Sobel; Michelle Lai; Richard Triglia; Megan Steain; Allison Abendroth; Ann Arvin
Journal:  J Virol       Date:  2011-10-19       Impact factor: 5.103

4.  Recombinant monoclonal antibody recognizes a unique epitope on varicella-zoster virus immediate-early 63 protein.

Authors:  Niklaus H Mueller; Nathan L Bos; Scott Seitz; Mary Wellish; Ravi Mahalingam; Don Gilden; Randall J Cohrs
Journal:  J Virol       Date:  2012-03-21       Impact factor: 5.103

5.  Analysis of T cell responses during active varicella-zoster virus reactivation in human ganglia.

Authors:  Megan Steain; Jeremy P Sutherland; Michael Rodriguez; Anthony L Cunningham; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2013-12-18       Impact factor: 5.103

Review 6.  Review: The neurobiology of varicella zoster virus infection.

Authors:  D Gilden; R Mahalingam; M A Nagel; S Pugazhenthi; R J Cohrs
Journal:  Neuropathol Appl Neurobiol       Date:  2011-08       Impact factor: 8.090

7.  Varicella-Zoster Virus ORF63 Protects Human Neuronal and Keratinocyte Cell Lines from Apoptosis and Changes Its Localization upon Apoptosis Induction.

Authors:  Chelsea Gerada; Megan Steain; Brian P McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

8.  Characterization of the host immune response in human Ganglia after herpes zoster.

Authors:  Kavitha Gowrishankar; Megan Steain; Anthony L Cunningham; Michael Rodriguez; Peter Blumbergs; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2010-06-23       Impact factor: 5.103

9.  Influence of frequent infectious exposures on general and varicella-zoster virus-specific immune responses in pediatricians.

Authors:  Benson Ogunjimi; Evelien Smits; Steven Heynderickx; Johan Van den Bergh; Joke Bilcke; Hilde Jansens; Ronald Malfait; Jose Ramet; Holden T Maecker; Nathalie Cools; Philippe Beutels; Pierre Van Damme
Journal:  Clin Vaccine Immunol       Date:  2014-01-15

Review 10.  Varicella zoster virus infection.

Authors:  Anne A Gershon; Judith Breuer; Jeffrey I Cohen; Randall J Cohrs; Michael D Gershon; Don Gilden; Charles Grose; Sophie Hambleton; Peter G E Kennedy; Michael N Oxman; Jane F Seward; Koichi Yamanishi
Journal:  Nat Rev Dis Primers       Date:  2015-07-02       Impact factor: 52.329

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.